Cardio Diagnostics CEO Discusses Growth Strategy and India Expansion on BioMedWire Podcast

Cardio Diagnostics Holdings (NASDAQ: CDIO) recently featured on The BioMedWire Podcast, where CEO and Co-Founder Dr. Meesha Dogan outlined the company's strategy to revolutionize cardiovascular disease prevention and early detection using precision medicine that integrates epigenetics, genetics, and artificial intelligence. The episode underscored the clinical and market potential of Cardio Diagnostics' AI-driven Integrated Genetic-Epigenetic Engine.

Dr. Dogan emphasized the company's expansion into India through strategic partnerships with Aimil Ltd. and Dr. Lal PathLabs, aiming to address the growing burden of cardiovascular disease in one of the world's most populous nations. This move aligns with Cardio Diagnostics' mission to make cardiovascular care more accessible globally.

The CEO also provided updates on the Medicare reimbursement process, noting that CPT coding and payment steps have been completed, while coverage determination remains in progress. This milestone is critical for broader adoption of the company's precision medicine tests among U.S. patients and healthcare providers.

Cardio Diagnostics leverages a proprietary AI-driven Integrated Genetic-Epigenetic Engine to develop clinical tests that improve prevention, detection, and treatment of cardiovascular disease. The company's focus on personalized medicine aims to reduce the global impact of heart disease, which remains a leading cause of death.

For more details, the full press release is available at https://ibn.fm/0VjIz. Investors can find the latest news and updates regarding CDIO in the company's newsroom at https://ibn.fm/CDIO.

The BioMedWire podcast episode highlights the convergence of biotechnology and artificial intelligence in cardiovascular medicine, showcasing Cardio Diagnostics as a key player in this evolving field. The company's progress in regulatory and reimbursement pathways could set a precedent for similar precision medicine initiatives.